I have a flow system

Chapter 287 2020 Financial Review

The purpose of Mr. Yuan’s research is to prevent the Chinese people from being hungry as much as possible, and at the same time, it also provides a possibility of survival for the hundreds of millions of people who are still hungry.

The meaning of Wu Zhou's company is to make people eat better.

Mr. Yuan’s value is far beyond what Wu Zhou is doing right now, which is why countless netizens jokingly call Mr. Yuan the contemporary God of Agriculture.

This set of flexible exoskeletons is a "hurried" work. After all, judging from the future time, Mr. Yuan may accidentally do something wrong next time.
So seeing that the time was getting closer, Wu Zhou went directly into the laboratory, got the flexible electrochromic material, and subsequently 'finalized' multiple test directions on his own initiative, greatly shortening the product's launch time.

However, even if the relevant technical problems have been solved, it will still take some time for industrial mass production.

After Wu Zhou returned to Yuncheng, he went directly back to the company and was about to celebrate the New Year.

The company is finalizing its financial accounting and year-end plans.

Some senior officials suggested that we hold an internal party or something to liven up the atmosphere, but Wu Zhou rejected it.

"In the current situation, if we hold an annual meeting, the crowd is too dense and it is very unsafe, so we won't hold it anymore. Moreover, the annual meeting actually has little meaning. If employees are not happy in the company, whether they can continue to work, the point is not whether the annual meeting is good or not. "The main thing is whether you are happy at work and whether the salary is enough, so if you have the money for the annual meeting, it is better to give it directly to the employees." Wu Zhou made the final decision.

Many unexpected things happened in 2020.

Even Wu Zhou himself did not expect that this year's development would reach such an extent.

Conventional products, Qiao Fei's snacks, and fast food continued to sell well from the beginning to the end of the year. Under the premise of a huge base, some products still brought high growth of several times or even dozens of times.

As for masks, this urgently needed product has always been in short supply. Even if foreign countries relaxed their policies in the later period, the popularity of mask sales has not changed. Tens of billions of masks have entered all parts of the world through various routes. Half of them are sold abroad.
As for the medical equipment produced by the company, tens of thousands of hospitals and tens of millions of patients have used Aiying Medical's oxygen concentrators, giving them a little more life.

The feedback of machine failures so far also proves the quality of the product, making medical staff in major hospitals realize that the quality of Aiying Medical products is reliable and excellent.

Then there is the world's first 'mask vaccine' to be launched.
This social significance is very great, and it also brought a lot of economic benefits to Wu Zhou.

And finally, Wu Zhou's newly established Aiying Technology released a work that 'shocked' the world, Huimeng AI, which once again ignited global topics and overshadowed the popularity of this vaccine.
In the eyes of the outside world, Wu Zhou has never been on the hot search list from beginning to end in 2020.

His net worth, according to the news, went from being the youngest billionaire at the beginning, to a billionaire, and finally became unknown.
In addition, there are some more titles.

"The Miracle Worker"

“Guardians of global human health.”

"Entrepreneurs who changed the world"

"Technology leader leading the development of next-generation AI"

and "God's beloved"

then
Many big shots even ask questions about Wu Zhou in public interviews.

In this case, it can bring a lot of heat.

Of course, China's positive image is 'deeply rooted', but in foreign media, it is completely the opposite.

Originally, because the company is a Chinese enterprise, it will naturally be disliked by many 'consumers'. In addition, Wuzhou Company's masks have made huge profits.

Finally, the vaccine of Aiying Biotech was launched and became the first related vaccine to be launched in the world.

You must know that during the same period, there were probably more than 200 related vaccine projects under development around the world, and only 15 of them have reached the human clinical trial stage.

But in the end, the one that made the fastest progress was Wu Zhou’s Aiying creature.

The two biopharmaceutical companies in the United States were also accelerating the progress of the vaccine launch, but just when they were about to get there, the relevant leaders were exposed. They had accepted bribes from pharmaceutical companies, and the vaccines of the two pharmaceutical companies were still being tested in humans. During the experiment, serious side effects occurred and there were major safety risks. After this news was exposed, although it was quickly reported simultaneously around the world, within a few hours, OMI's mainstream media and Internet platforms removed the relevant news.

That is, after all, Omi is not the only one in the world. They only account for about 15% of the world's population. After people in other countries saw this news, their hopes fell on Wu Zhou's Aiying Biotechnology.

In only about two days, the media from OMI exposed that the inactivated vaccine of Aiying Biotechnology also had serious side effects and had significant unknown risks.
However, this news only became a "hot search" on OMI, because some netizens predicted OMI's prediction in advance, and stated in advance that OMI will definitely issue similar news later to slander the China Aiying Biovaccine. Fame, and then create news, and in the news, no conclusive evidence will be given, just assumptions and inferences.

This comment was mixed in with previous comments about the vaccine scandal at Omega.

Of course, there is another inference besides this.

"Although the news has revealed that these vaccines have safety risks, the market for this vaccine is very huge. As the largest biopharmaceutical company in Omi, the vaccine will definitely be on the market in the end, it's just a matter of time."

"No way. Aren't there many vaccines undergoing human trials around the world?"

"But currently only China's vaccine is successful, and the vaccine from OMI is closest to success. In addition, vaccines from other countries have many problems."

"Okay, I understand, use China's vaccine."

Of course, there are also some public figures in China who ridicule domestic vaccines and compare imported products with domestic products. The meaning is self-evident.

However, no amount of cynicism can offset the fact that there is probably only one vaccine from Aiying Biotech on the market.

Either those who are tough-talking will wait until the imported vaccine they think can be produced before taking the vaccine, or they can pinch their noses and use the vaccine from Aiying Biotechnology.

In more than 200 countries and regions around the world, only a minority of the minority are actually capable of developing vaccines. In addition, because it is a 'single vaccine', Aiying Biotech's vaccine has been sought after by most countries around the world.

Aiying Biotech’s vaccine production line is in full swing.

The export of related technologies is also under the guidance of the state, selectively exporting products or exporting a complete set of technologies.

However, during that time, Aiying Biology was the hot topic, but Wu Zhou had been busy with Aiying Technology.

The emergence of Eimengai, its overwhelming popularity, and the technological superiority of Eimengai have also made many ordinary people who were originally skeptical of "Aiying Biology" become less interested in such a name as Aiying Biology. A little-known company created a sense of trust.

By the time 2020 is over, Aiying Bio's vaccine orders have reached 7 million. The average supply price of 5 million domestically is about 50 yuan per vaccine, and 2 million will be shipped abroad at a single price of 200 yuan. The total return The amount of the loan is 650 billion.

The estimated gross profit is about 500 billion.
The original purchase of the related biopharmaceutical company + medical device company totaled only about 250 billion. Coupled with Wu Zhou's large R&D investment in the later period, poaching and a series of other measures, the gross estimate was less than 100 billion.

Over time, Wu Zhou's investment of less than 350 billion yuan was less than a year's return, and he earned an excess profit of 150 billion +. Of course, these are gross calculations, and there are many tax aspects that have not been calculated carefully.

And no surprise, in 2021, Aiying Bio's revenue and profits may reach a higher level. The important thing is that the capital will be returned in 2020.
Damn it, this is a proper money printing machine.
Of course, although this is enough to make people jealous, it is only one of Wu Zhou Company’s income in 2020, and it is only a small part.
The biggest one is the mask, which has been selling well from the beginning of the year to the end of the year, and is in short supply almost all year round. It is a hot-selling mask throughout the year, across the country, and even around the world.

A total of more than 1381 billion units were sold, bringing the company revenue of billion.
Because overseas supply was completely in short supply in the early stage, masks were out of stock globally, and the use of US dollars as the settlement currency resulted in a direct super high premium. Then the profit reached an outrageous and highly unlikely to be replicated 981 billion.

Finally, it is the main business of Aiying Group.

Big food includes snacks, fast food, and the like, both online and offline. Because of its wealth and popularity, Aiying Group's products have been fully rolled out across the country this year, even in ordinary supermarkets in small counties and convenience stores in small towns. You can see related products.

The direct result of this is that the total revenue reached 781 billion.

The total revenue of large department stores is 82 billion, excluding masks, and 19 billion from maternal and infant products. The total sales are 882 billion, and the profit is 393 billion.

Finally, medical equipment such as oxygen generators, air disinfection purifiers, fresh air fans, virus detectors, etc., sold a total of 328 billion and made a profit of 135 billion.

In general, Wu Zhou's company, excluding Aiying Technology, has a total revenue of 3241 billion, a total profit of 2009 billion, and a gross profit margin of 61.99%. (Aiying Technology is calculated separately, because although this company is named Aiying, it is actually mostly funded by Wu Zhou himself and in cooperation with Juchang)

(End of this chapter)